These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 17308100

  • 1. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death.
    Steták A, Veress R, Ovádi J, Csermely P, Kéri G, Ullrich A.
    Cancer Res; 2007 Feb 15; 67(4):1602-8. PubMed ID: 17308100
    [Abstract] [Full Text] [Related]

  • 2. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.
    Spoden GA, Rostek U, Lechner S, Mitterberger M, Mazurek S, Zwerschke W.
    Exp Cell Res; 2009 Oct 01; 315(16):2765-74. PubMed ID: 19563799
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
    Mazurek S, Drexler HC, Troppmair J, Eigenbrodt E, Rapp UR.
    Anticancer Res; 2007 Oct 01; 27(6B):3963-71. PubMed ID: 18225557
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation.
    Spoden GA, Mazurek S, Morandell D, Bacher N, Ausserlechner MJ, Jansen-Dürr P, Eigenbrodt E, Zwerschke W.
    Int J Cancer; 2008 Jul 15; 123(2):312-321. PubMed ID: 18425820
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells.
    Gumińska M, Ignacak J, Kedryna T, Stachurska MB.
    Acta Biochim Pol; 1997 Jul 15; 44(4):711-24. PubMed ID: 9584851
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
    Zhan C, Yan L, Wang L, Ma J, Jiang W, Zhang Y, Shi Y, Wang Q.
    PLoS One; 2015 Jul 15; 10(3):e0118663. PubMed ID: 25738776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.